• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE

RECCE PHARMACEUTICALS LTD - Announcements

3.57% ! 29.0¢
Market Cap $72.42M  !

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

Recce accelerates commercialisation

Announcements



RCE Ceasing to be a substantial holder from MQG23/04/25 download Created with Sketch. 151.54KB
RCE Investor Webinar Recording Available23/04/25 download Created with Sketch. 135KB
RCE Entitlement Offer - Notification to Ineligible Shareholders22/04/25 download Created with Sketch. 235.57KB
RCE Entitlement Offer - Offer Booklet and Access LetterPRICE SENSITIVE22/04/25 download Created with Sketch. 990.5KB
RCE Phase II Clinical Trial Receives Additional Approval for DFIPRICE SENSITIVE22/04/25 download Created with Sketch. 220.81KB
RCE Cleansing Notice17/04/25 download Created with Sketch. 194.57KB
RCE Placement Settlement Completed17/04/25 download Created with Sketch. 215.86KB
RCE Application for quotation of securities - RCE17/04/25 download Created with Sketch. 15.92KB
RCE RCE Investor Webinar Presentation15/04/25 download Created with Sketch. 86.42KB
RCE Equity Raising Presentation10/04/25 download Created with Sketch. 1.95MB
RCE Cleansing Notice - Entitlement Offer10/04/25 download Created with Sketch. 220.61KB
RCE Placement and Entitlement Offer to Fund Phase III TrialsPRICE SENSITIVE10/04/25 download Created with Sketch. 247.13KB
RCE Proposed issue of securities - RCE10/04/25 download Created with Sketch. 25.41KB
RCE Becoming a substantial holder from MQG28/03/25 download Created with Sketch. 156.51KB
RCE RCE Corporate Presentation20/03/25 download Created with Sketch. 1.94MB
RCE Key Opinion Leader PresentationPRICE SENSITIVE03/03/25 download Created with Sketch. 3.75MB
RCE RCE Clinical Milestones Investor Webinar28/02/25 download Created with Sketch. 126.01KB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE28/02/25 download Created with Sketch. 734.76KB
RCE Japan Patent Allowance for RECCE Anti-InfectivesPRICE SENSITIVE26/02/25 download Created with Sketch. 284.64KB
RCE Positive Phase II Data from Clinical Trial of R327 GelPRICE SENSITIVE17/02/25 download Created with Sketch. 265.3KB
RCE Trading HaltPRICE SENSITIVE13/02/25 download Created with Sketch. 240.14KB
RCE Pause in TradingPRICE SENSITIVE13/02/25 download Created with Sketch. 115.54KB
RCE Correction to Appendix 4C and Quarterly Activities ReportPRICE SENSITIVE06/02/25 download Created with Sketch. 370.23KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/25 download Created with Sketch. 367.68KB
RCE Patient Dosing Complete in Phase II ABSSSI Trial of R327GPRICE SENSITIVE21/01/25 download Created with Sketch. 286.92KB
RCE Regulatory Approval for Registrational Phase 3 R327G TrialPRICE SENSITIVE09/12/24 download Created with Sketch. 265.32KB
RCE Trading HaltPRICE SENSITIVE05/12/24 download Created with Sketch. 567.51KB
RCE Presentation - Ord Minnett Biotech & MedTech Conference28/11/24 download Created with Sketch. 2.46MB
RCE Australia Patent Granted for RECCE Anti-InfectivesPRICE SENSITIVE26/11/24 download Created with Sketch. 213.38KB
RCE Change of Director's Interest Notices21/11/24 download Created with Sketch. 1.34MB
RCE Notification regarding unquoted securities - RCE21/11/24 download Created with Sketch. 19.34KB
RCE AUD $6.75m R&D Rebate ApprovedPRICE SENSITIVE14/11/24 download Created with Sketch. 208.49KB
RCE Notification regarding unquoted securities - RCE13/11/24 download Created with Sketch. 18.34KB
RCE Ethics Approval for Registrational Ph3 R327G Clinical TrialPRICE SENSITIVE11/11/24 download Created with Sketch. 292.32KB
RCE Constitution06/11/24 download Created with Sketch. 586.98KB
RCE Results of Special General Meeting06/11/24 download Created with Sketch. 161.46KB
RCE Results of Annual General Meeting06/11/24 download Created with Sketch. 167.63KB
RCE AGM PresentationPRICE SENSITIVE06/11/24 download Created with Sketch. 1.1MB
RCE Phase II ABSSSI Clinical Trial Advances to Final StagesPRICE SENSITIVE05/11/24 download Created with Sketch. 303.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/24 download Created with Sketch. 922.43KB
RCE Efficacy Data & Approval to Continue Ph II ABSSSI TrialPRICE SENSITIVE28/10/24 download Created with Sketch. 279.9KB
RCE Ph II ABSSSI Trial Recruitment and Dosing Passes HalfwayPRICE SENSITIVE09/10/24 download Created with Sketch. 263.73KB
RCE Notice of Special General Meeting/Proxy FormPRICE SENSITIVE08/10/24 download Created with Sketch. 586.49KB
RCE Notice of Annual General Meeting/Proxy Form08/10/24 download Created with Sketch. 12.32MB
RCE Notification of buy-back - RCE08/10/24 download Created with Sketch. 13.54KB
RCE Cleansing Notice26/09/24 download Created with Sketch. 195.16KB
RCE Application for quotation of securities - RCE26/09/24 download Created with Sketch. 16.68KB
RCE 2024 Annual General Meeting16/09/24 download Created with Sketch. 164.95KB
RCE Appendix 4G30/08/24 download Created with Sketch. 278.33KB
RCE Annual Report to Shareholders30/08/24 download Created with Sketch. 12.91MB
RCE Preliminary Final ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 126.72KB
RCE Securities Trading Policy06/08/24 download Created with Sketch. 324.59KB
RCE Application for quotation of securities - RCE06/08/24 download Created with Sketch. 15.7KB
RCE Successful Completion of Share Purchase PlanPRICE SENSITIVE05/08/24 download Created with Sketch. 242.48KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE26/07/24 download Created with Sketch. 926.64KB
RCE US Department of Defense Grants US $2m for R327GPRICE SENSITIVE15/07/24 download Created with Sketch. 346.08KB
RCE Change of Auditor11/07/24 download Created with Sketch. 181.17KB
RCE Share Purchase Plan - Letter and Offer Booklet10/07/24 download Created with Sketch. 813.71KB
RCE Cleansing Notice09/07/24 download Created with Sketch. 212.8KB
RCE Application for quotation of securities - RCE09/07/24 download Created with Sketch. 15.85KB
RCE R327 Efficacy against WHO Priority Pathogen Acinetobacter BPRICE SENSITIVE08/07/24 download Created with Sketch. 504.85KB
RCE Equity Raising Presentation02/07/24 download Created with Sketch. 2.96MB
RCE Proposed issue of securities - RCE02/07/24 download Created with Sketch. 23.91KB
RCE Placement & SPP to raise $10 million - Funded to FY26PRICE SENSITIVE02/07/24 download Created with Sketch. 299.88KB
RCE Trading HaltPRICE SENSITIVE01/07/24 download Created with Sketch. 565.47KB
RCE Clarification - Phase I/II UTI/Urosepsis Fast Infusion Trial01/07/24 download Created with Sketch. 140.54KB
RCE Phase I/II UTI/Urosepsis Rapid Infusion Trial CompletePRICE SENSITIVE28/06/24 download Created with Sketch. 381.7KB
RCE Ethics Approval Broadens to All Topical InfectionsPRICE SENSITIVE24/06/24 download Created with Sketch. 345.82KB
RCE Further R&D Rebate ApprovedPRICE SENSITIVE18/06/24 download Created with Sketch. 224.3KB
RCE R327 added to WHO List of Antibacterial ProductsPRICE SENSITIVE18/06/24 download Created with Sketch. 565.63KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical TrialPRICE SENSITIVE11/06/24 download Created with Sketch. 262.74KB
RCE Military Health Research Symposium Abstract & Presentation03/06/24 download Created with Sketch. 239.99KB
RCE Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next CohortPRICE SENSITIVE15/05/24 download Created with Sketch. 239.86KB
RCE Cleansing Statement10/05/24 download Created with Sketch. 195.17KB
RCE Application for quotation of securities - RCE10/05/24 download Created with Sketch. 17.23KB
RCE MCRI Pilot Study- Positive Efficacy Data for Lung InfectionsPRICE SENSITIVE09/05/24 download Created with Sketch. 498KB
RCE China Patent Granted for RECCE Anti-InfectivesPRICE SENSITIVE07/05/24 download Created with Sketch. 241.55KB
RCE Safety Committee Approves High Dose of 4,000mgPRICE SENSITIVE26/04/24 download Created with Sketch. 263.52KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE22/04/24 download Created with Sketch. 575.83KB
RCE Cleansing Statement16/04/24 download Created with Sketch. 193.34KB
RCE Application for quotation of securities - RCE16/04/24 download Created with Sketch. 16.67KB
RCE Recce Completes 5,000 R327 Doses Per Week under GMPPRICE SENSITIVE16/04/24 download Created with Sketch. 217.27KB
RCE Recce Pharmaceuticals - Business UpdatePRICE SENSITIVE08/04/24 download Created with Sketch. 582.67KB
RCE Patent Granted in Israel for RECCE Anti-InfectivesPRICE SENSITIVE03/04/24 download Created with Sketch. 324.65KB
RCE RECCE Trademark Registered - Canada21/03/24 download Created with Sketch. 216.83KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical TrialPRICE SENSITIVE15/03/24 download Created with Sketch. 278.98KB
RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical TrialPRICE SENSITIVE12/03/24 download Created with Sketch. 262.97KB
RCE Recce Receives AUD $11.17m R&D AdvancePRICE SENSITIVE08/03/24 download Created with Sketch. 238.07KB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE27/02/24 download Created with Sketch. 464.55KB
RCE Notification of cessation of securities - RCE27/02/24 download Created with Sketch. 12.78KB
RCE Recce Continues Strategic Partnership with MCRI27/02/24 download Created with Sketch. 274.91KB
RCE Safety Committee Approves Expansion of Ph I/II DFI TrialPRICE SENSITIVE26/02/24 download Created with Sketch. 246.18KB
RCE MoU Clarification Announcement13/02/24 download Created with Sketch. 170.43KB
RCE RCE Establishes Strategic Partnership in South-East AsiaPRICE SENSITIVE06/02/24 download Created with Sketch. 451.89KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/24 download Created with Sketch. 746.24KB
RCE Positive Ph I/II DFI Efficacy Data to Support Site ExpansionPRICE SENSITIVE18/01/24 download Created with Sketch. 266.33KB
RCE Murdoch Children's R327 Efficacy UTI in-vivoPRICE SENSITIVE28/12/23 download Created with Sketch. 384.21KB
RCE RCE Awarded Further $11.17m Advanced Overseas FindingPRICE SENSITIVE15/12/23 download Created with Sketch. 382.33KB
RCE Change of Director's Interest Notices14/12/23 download Created with Sketch. 908.39KB
RCE RCE Awarded $43.7m AusIndustry Advanced Overseas FindingPRICE SENSITIVE14/12/23 download Created with Sketch. 376.84KB
RCE Ceasing to be a substantial holder from MQG
23/04/25 download Created with Sketch. 151.54KB
RCE Investor Webinar Recording Available
23/04/25 download Created with Sketch. 135KB
RCE Entitlement Offer - Notification to Ineligible Shareholders
22/04/25 download Created with Sketch. 235.57KB
RCE Entitlement Offer - Offer Booklet and Access Letter
22/04/25PRICE SENSITIVE download Created with Sketch. 990.5KB
RCE Phase II Clinical Trial Receives Additional Approval for DFI
22/04/25PRICE SENSITIVE download Created with Sketch. 220.81KB
RCE Cleansing Notice
17/04/25 download Created with Sketch. 194.57KB
RCE Placement Settlement Completed
17/04/25 download Created with Sketch. 215.86KB
RCE Application for quotation of securities - RCE
17/04/25 download Created with Sketch. 15.92KB
RCE RCE Investor Webinar Presentation
15/04/25 download Created with Sketch. 86.42KB
RCE Equity Raising Presentation
10/04/25 download Created with Sketch. 1.95MB
RCE Cleansing Notice - Entitlement Offer
10/04/25 download Created with Sketch. 220.61KB
RCE Placement and Entitlement Offer to Fund Phase III Trials
10/04/25PRICE SENSITIVE download Created with Sketch. 247.13KB
RCE Proposed issue of securities - RCE
10/04/25 download Created with Sketch. 25.41KB
RCE Becoming a substantial holder from MQG
28/03/25 download Created with Sketch. 156.51KB
RCE RCE Corporate Presentation
20/03/25 download Created with Sketch. 1.94MB
RCE Key Opinion Leader Presentation
03/03/25PRICE SENSITIVE download Created with Sketch. 3.75MB
RCE RCE Clinical Milestones Investor Webinar
28/02/25 download Created with Sketch. 126.01KB
RCE Appendix 4D and Interim Financial Report
28/02/25PRICE SENSITIVE download Created with Sketch. 734.76KB
RCE Japan Patent Allowance for RECCE Anti-Infectives
26/02/25PRICE SENSITIVE download Created with Sketch. 284.64KB
RCE Positive Phase II Data from Clinical Trial of R327 Gel
17/02/25PRICE SENSITIVE download Created with Sketch. 265.3KB
RCE Trading Halt
13/02/25PRICE SENSITIVE download Created with Sketch. 240.14KB
RCE Pause in Trading
13/02/25PRICE SENSITIVE download Created with Sketch. 115.54KB
RCE Correction to Appendix 4C and Quarterly Activities Report
06/02/25PRICE SENSITIVE download Created with Sketch. 370.23KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25PRICE SENSITIVE download Created with Sketch. 367.68KB
RCE Patient Dosing Complete in Phase II ABSSSI Trial of R327G
21/01/25PRICE SENSITIVE download Created with Sketch. 286.92KB
RCE Regulatory Approval for Registrational Phase 3 R327G Trial
09/12/24PRICE SENSITIVE download Created with Sketch. 265.32KB
RCE Trading Halt
05/12/24PRICE SENSITIVE download Created with Sketch. 567.51KB
RCE Presentation - Ord Minnett Biotech & MedTech Conference
28/11/24 download Created with Sketch. 2.46MB
RCE Australia Patent Granted for RECCE Anti-Infectives
26/11/24PRICE SENSITIVE download Created with Sketch. 213.38KB
RCE Change of Director's Interest Notices
21/11/24 download Created with Sketch. 1.34MB
RCE Notification regarding unquoted securities - RCE
21/11/24 download Created with Sketch. 19.34KB
RCE AUD $6.75m R&D Rebate Approved
14/11/24PRICE SENSITIVE download Created with Sketch. 208.49KB
RCE Notification regarding unquoted securities - RCE
13/11/24 download Created with Sketch. 18.34KB
RCE Ethics Approval for Registrational Ph3 R327G Clinical Trial
11/11/24PRICE SENSITIVE download Created with Sketch. 292.32KB
RCE Constitution
06/11/24 download Created with Sketch. 586.98KB
RCE Results of Special General Meeting
06/11/24 download Created with Sketch. 161.46KB
RCE Results of Annual General Meeting
06/11/24 download Created with Sketch. 167.63KB
RCE AGM Presentation
06/11/24PRICE SENSITIVE download Created with Sketch. 1.1MB
RCE Phase II ABSSSI Clinical Trial Advances to Final Stages
05/11/24PRICE SENSITIVE download Created with Sketch. 303.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24PRICE SENSITIVE download Created with Sketch. 922.43KB
RCE Efficacy Data & Approval to Continue Ph II ABSSSI Trial
28/10/24PRICE SENSITIVE download Created with Sketch. 279.9KB
RCE Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway
09/10/24PRICE SENSITIVE download Created with Sketch. 263.73KB
RCE Notice of Special General Meeting/Proxy Form
08/10/24PRICE SENSITIVE download Created with Sketch. 586.49KB
RCE Notice of Annual General Meeting/Proxy Form
08/10/24 download Created with Sketch. 12.32MB
RCE Notification of buy-back - RCE
08/10/24 download Created with Sketch. 13.54KB
RCE Cleansing Notice
26/09/24 download Created with Sketch. 195.16KB
RCE Application for quotation of securities - RCE
26/09/24 download Created with Sketch. 16.68KB
RCE 2024 Annual General Meeting
16/09/24 download Created with Sketch. 164.95KB
RCE Appendix 4G
30/08/24 download Created with Sketch. 278.33KB
RCE Annual Report to Shareholders
30/08/24 download Created with Sketch. 12.91MB
RCE Preliminary Final Report
30/08/24PRICE SENSITIVE download Created with Sketch. 126.72KB
RCE Securities Trading Policy
06/08/24 download Created with Sketch. 324.59KB
RCE Application for quotation of securities - RCE
06/08/24 download Created with Sketch. 15.7KB
RCE Successful Completion of Share Purchase Plan
05/08/24PRICE SENSITIVE download Created with Sketch. 242.48KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
26/07/24PRICE SENSITIVE download Created with Sketch. 926.64KB
RCE US Department of Defense Grants US $2m for R327G
15/07/24PRICE SENSITIVE download Created with Sketch. 346.08KB
RCE Change of Auditor
11/07/24 download Created with Sketch. 181.17KB
RCE Share Purchase Plan - Letter and Offer Booklet
10/07/24 download Created with Sketch. 813.71KB
RCE Cleansing Notice
09/07/24 download Created with Sketch. 212.8KB
RCE Application for quotation of securities - RCE
09/07/24 download Created with Sketch. 15.85KB
RCE R327 Efficacy against WHO Priority Pathogen Acinetobacter B
08/07/24PRICE SENSITIVE download Created with Sketch. 504.85KB
RCE Equity Raising Presentation
02/07/24 download Created with Sketch. 2.96MB
RCE Proposed issue of securities - RCE
02/07/24 download Created with Sketch. 23.91KB
RCE Placement & SPP to raise $10 million - Funded to FY26
02/07/24PRICE SENSITIVE download Created with Sketch. 299.88KB
RCE Trading Halt
01/07/24PRICE SENSITIVE download Created with Sketch. 565.47KB
RCE Clarification - Phase I/II UTI/Urosepsis Fast Infusion Trial
01/07/24 download Created with Sketch. 140.54KB
RCE Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
28/06/24PRICE SENSITIVE download Created with Sketch. 381.7KB
RCE Ethics Approval Broadens to All Topical Infections
24/06/24PRICE SENSITIVE download Created with Sketch. 345.82KB
RCE Further R&D Rebate Approved
18/06/24PRICE SENSITIVE download Created with Sketch. 224.3KB
RCE R327 added to WHO List of Antibacterial Products
18/06/24PRICE SENSITIVE download Created with Sketch. 565.63KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
11/06/24PRICE SENSITIVE download Created with Sketch. 262.74KB
RCE Military Health Research Symposium Abstract & Presentation
03/06/24 download Created with Sketch. 239.99KB
RCE Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort
15/05/24PRICE SENSITIVE download Created with Sketch. 239.86KB
RCE Cleansing Statement
10/05/24 download Created with Sketch. 195.17KB
RCE Application for quotation of securities - RCE
10/05/24 download Created with Sketch. 17.23KB
RCE MCRI Pilot Study- Positive Efficacy Data for Lung Infections
09/05/24PRICE SENSITIVE download Created with Sketch. 498KB
RCE China Patent Granted for RECCE Anti-Infectives
07/05/24PRICE SENSITIVE download Created with Sketch. 241.55KB
RCE Safety Committee Approves High Dose of 4,000mg
26/04/24PRICE SENSITIVE download Created with Sketch. 263.52KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
22/04/24PRICE SENSITIVE download Created with Sketch. 575.83KB
RCE Cleansing Statement
16/04/24 download Created with Sketch. 193.34KB
RCE Application for quotation of securities - RCE
16/04/24 download Created with Sketch. 16.67KB
RCE Recce Completes 5,000 R327 Doses Per Week under GMP
16/04/24PRICE SENSITIVE download Created with Sketch. 217.27KB
RCE Recce Pharmaceuticals - Business Update
08/04/24PRICE SENSITIVE download Created with Sketch. 582.67KB
RCE Patent Granted in Israel for RECCE Anti-Infectives
03/04/24PRICE SENSITIVE download Created with Sketch. 324.65KB
RCE RECCE Trademark Registered - Canada
21/03/24 download Created with Sketch. 216.83KB
RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
15/03/24PRICE SENSITIVE download Created with Sketch. 278.98KB
RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
12/03/24PRICE SENSITIVE download Created with Sketch. 262.97KB
RCE Recce Receives AUD $11.17m R&D Advance
08/03/24PRICE SENSITIVE download Created with Sketch. 238.07KB
RCE Appendix 4D and Interim Financial Report
27/02/24PRICE SENSITIVE download Created with Sketch. 464.55KB
RCE Notification of cessation of securities - RCE
27/02/24 download Created with Sketch. 12.78KB
RCE Recce Continues Strategic Partnership with MCRI
27/02/24 download Created with Sketch. 274.91KB
RCE Safety Committee Approves Expansion of Ph I/II DFI Trial
26/02/24PRICE SENSITIVE download Created with Sketch. 246.18KB
RCE MoU Clarification Announcement
13/02/24 download Created with Sketch. 170.43KB
RCE RCE Establishes Strategic Partnership in South-East Asia
06/02/24PRICE SENSITIVE download Created with Sketch. 451.89KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24PRICE SENSITIVE download Created with Sketch. 746.24KB
RCE Positive Ph I/II DFI Efficacy Data to Support Site Expansion
18/01/24PRICE SENSITIVE download Created with Sketch. 266.33KB
RCE Murdoch Children's R327 Efficacy UTI in-vivo
28/12/23PRICE SENSITIVE download Created with Sketch. 384.21KB
RCE RCE Awarded Further $11.17m Advanced Overseas Finding
15/12/23PRICE SENSITIVE download Created with Sketch. 382.33KB
RCE Change of Director's Interest Notices
14/12/23 download Created with Sketch. 908.39KB
RCE RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
14/12/23PRICE SENSITIVE download Created with Sketch. 376.84KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
29.0¢
Change
0.010(3.57%)
Mkt cap ! $72.42M
Open High Low Value Volume
29.0¢ 29.0¢ 28.0¢ $33.07K 114.5K

Buyers (Bids)

No. Vol. Price($)
1 10000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 26762 1
View Market Depth
Last trade - 16.10pm 23/04/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.